Company intelligence / Profile preview

PhaseV

Boston, Massachusetts, United Statesphasevtrials.com ↗

Ownership: Private
Development stage: Other

Overview

PhaseV’s AI/ML-driven clinical development platform has demonstrated significant impact in real-world settings—reducing trial costs by up to 50%, decreasing enrollment size and trial duration by up to 40%, and increasing the probability of trial success by over 30%. The technology has enabled sponsors to identify optimal patient subgroups and early endpoints that accelerate decision-making. Case studies include successful redesigns of failed or underperforming trials leading to improved outcomes

Therapeutic areas: OncologyMetabolic DisordersImmunologyRare DiseasesGastroenterologyNeurology
Modalities: Not modality-specific; platform is used across a wide range of therapeutic modalities, including small molecules, biologics, and others
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Alimentiv (GI-focused CRO)Quanticate (biometric CRO)NeuroSense Technologies (clinical-stage biotech)iOMEDICO (oncology/hematology CRO)

Beyond the preview

Go deeper on PhaseV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PhaseV.

Explore the full profile